Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats (Q30391868)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Abdallah Ahnaou

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Ria Biermans

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Wilhelmus H Drinkenburg

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

25 January 2016

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

e0147365

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

copyright license

Creative Commons Attribution 4.0 International

25 January 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Baseline gamma power during auditory steady-state stimulation in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Cognition in schizophrenia: core psychological and neural mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Evidence of abnormalities in mid-latency auditory evoked responses (MLAER) in cognitive subtypes of patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Abnormal neural oscillations and synchrony in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Increased hippocampal, thalamic, and prefrontal hemodynamic response to an urban noise stimulus in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Sensory gating: a translational effort from basic to clinical science

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Gamma-band auditory steady-state responses are impaired in first episode psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

EEG alpha oscillations: the inhibition-timing hypothesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Early-stage visual processing deficits in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Human EEG gamma oscillations in neuropsychiatric disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Neural synchrony indexes disordered perception and cognition in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Pre-attentive processing and schizophrenia: animal studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Immunohistochemical localization of PDE10A in the rat brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

The neurobiology of startle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

A primary acoustic startle circuit: lesion and stimulation studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Hippocampal electrical activity and voluntary movement in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

Presidential Address, 1974. The more or less startling effects of weak prestimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

20 June 2018

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Ear of stimulation determines schizophrenia-normal brain activity differences in an auditory paired-stimuli paradigm

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Transient impairment in P50 auditory sensory gating induced by a cold-pressor test

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

An agonist at glutamate and dopamine D2 receptors, LY404039.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Prepulse inhibition and P50 suppression: commonalities and dissociations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Attention and awareness in synchrony

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0147365

21 January 2018

Oscillatory brain activity dissociates between associative stimulus content in a repetition priming task in the human EEG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

26 November 2018

Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

26 November 2018

Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

26 November 2018

Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4726622

26 November 2018

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26808689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synchronous Gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26808689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantified EEG changes associated with a positive clinical response to clozapine in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26808689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0147365

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

2016PLoSO..1147365A

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30391868&oldid=1853852796"